Extended-Release Carvedilol in the Treatment of Hypertension: A Double-Blind, Randomized, Placebo-Controlled Trial

BACKGROUND: Immediate-release carvedilol requires twice-daily dosing and may have low treatment compliance. We assessed the efficacy of a new formulation of once-daily extended-release carvedilol (carvedilol ER) on systolic blood pressure (SBP) and diastolic blood pressure (DBP) among patients with...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Acta Cardiol Sin
Autors principals: Wang, Kang-Ling, Fang, Chih-Yuan, Lai, Wen-Ter, Wang, Tzung-Dau, Ueng, Kwo-Chang, Wang, Kuo-Yang, Wang, Ji-Hung, Shyu, Kou-Gi, Chiang, Chern-En
Format: Artigo
Idioma:Inglês
Publicat: Taiwan Society of Cardiology 2021
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7953114/
https://ncbi.nlm.nih.gov/pubmed/33716461
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6515/ACS.202103_37(2).20200914B
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars